Anthony D. Ormerod

Also affiliated with Bristol-Myers Squibb (Germany), Eli Lilly (United States), Pfizer (United Kingdom), University of Aberdeen, Leo Pharma (Australia), Janssen (France), Samsung (United States), Galderma (France), Boehringer Ingelheim (India), Almirall (Spain), NIHR Manchester Biomedical Research Centre

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial”.

Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial

British Journal of Dermatology(2023)10.1093/bjd/ljad281

N/A

0DataRank · unranked

43 citations

Anna Rosala‐Hallas, Ashley P Jones, Paula Beattie, Susannah Baron, Fiona Browne +54 more